| P2093 | author name string | B. de Lignieres | |
| P2860 | cites work | The New England Journal of Medicine | Q582728 |
| | American Journal of Physiology | Q2160146 |
| | Biological Actions of Androgens | Q22306226 |
| | The European journal of medicine | Q27710173 |
| | The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group | Q33970656 |
| | High prevalence of benign prostatic hypertrophy in the community | Q34001274 |
| | Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production | Q34024549 |
| | Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys | Q34215194 |
| | Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men. | Q34267080 |
| | Effects of androgen treatment on the male rat aorta | Q35897327 |
| | Sex hormone-binding globulin: Anatomy and physiology of a new regulatory system | Q36442161 |
| | Effect of testosterone cypionate on postexercise ST segment depression | Q36804813 |
| | Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal | Q36992492 |
| | Intracrinology | Q37124969 |
| | Clinical review 24: Androgens in the aging male | Q37194233 |
| | Etiology and disease process of benign prostatic hyperplasia | Q38211704 |
| | The induction of prostatic hypertrophy in the dog with androstanediol | Q39391653 |
| | Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study* | Q41140274 |
| | Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione | Q41342453 |
| | Effects in mice of testosterone and dihydrotestosterone on platelet aggregation in injured arterioles and ex vivo | Q41457679 |
| | Role of epithelial-stromal interactions in the control of gene expression in the prostate: an hypothesis | Q41476968 |
| | Dihydrotestosterone does not induce prostate adenocarcinoma in L-W rats | Q42218723 |
| | Effect of the Addition of Estrogen to Medical Castration on Prostatic Size, Symptoms, Histology and Serum Prostate Specific Antigen in 4 Men with Benign Prostatic Hypertrophy | Q42467070 |
| | Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma | Q42809391 |
| | Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry | Q43818419 |
| | Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters | Q44090648 |
| | Measurement of androgen sensitivity in the human prostate in in vitro three-dimensional histoculture | Q44437787 |
| | Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic | Q44856785 |
| | Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteins | Q48457380 |
| | Transient hypogonadotropic hypogonadism caused by critical illness | Q48515361 |
| | Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study | Q51606964 |
| | Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids | Q54407444 |
| | Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1 | Q56058535 |
| | Estrogens and Benign Prostatic Hyperplasia: Rationale for Therapy with Aromatase Inhibitors | Q58293564 |
| | Serum estrogen levels in men with acute myocardial infarction | Q59356632 |
| | Age-related decline of plasma bioavailable testosterone in adult men | Q67273869 |
| | Testosterone secretion and metabolism in male senescence | Q67294795 |
| | Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues | Q67465568 |
| | Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia | Q67654333 |
| | Androgens: risks and benefits | Q67691228 |
| | Lower endogenous androgens predict central adiposity in men | Q67875625 |
| | The relationship between cardiovascular complications of estrogen therapy and fibrinolysis in patients with prostatic cancer | Q68229349 |
| | Relationship between sex hormones and haemostatic factors in healthy middle-aged men | Q68388917 |
| | Oral contraceptives, lipoproteins, and atherosclerosis | Q68573234 |
| | Testosterone replacement therapy and sleep-related erections in hypogonadal men | Q68717214 |
| | Osteoporosis in men with idiopathic hypogonadotropic hypogonadism | Q68933066 |
| | Concentrations of androgens in human benign prostatic hypertrophic tissues incubated for up to three days | Q68972497 |
| | Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia | Q68979568 |
| | Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition | Q69013900 |
| | Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy | Q69090680 |
| | Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease | Q69863090 |
| | Age dependency of androgen and estrogen effects on incorporation of (3H)-thymidine by rat prostates in organ culture | Q69995298 |
| | Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men | Q70290413 |
| | Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis | Q70299192 |
| | Percutaneous absorption of 5 alpha-dihydrotestosterone in man. II. Percutaneous administration of 5 alpha-dihydrotestosterone in hypogonadal men with idiopathic haemochromatosis; clinical, metabolic and hormonal effectiveness | Q70563981 |
| | The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma | Q70652481 |
| | Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men | Q70659442 |
| | Serum estradiol levels in male cigarette smokers | Q70664132 |
| | New puzzles over estrogen and heart disease | Q71750884 |
| | Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate | Q72677691 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 235-241 | |
| P577 | publication date | 1993-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Transdermal Dihydrotestosterone Treatment of 'Andropause' | |
| P478 | volume | 25 | |